TAPIJ: Stress and Diabetes Insights
TAPIJ: Stress and Diabetes Insights
Dear Colleagues,
It's a great pleasure to present you this issue of TAPIJ, which contains valuable articles
that expands your existing knowledge of medicine.
We have two excellent review articles in this issue of TAPIJ. The article on “Approach to
diagnosis and treatment of Epilepsies” details on its pathogenesis, diagnostic aspects, treatment
options and management in the clinical settings. Another review article on the “Stress and
Diabetes” emphasizes the role of stress on insulin resistance.
We also have four detailed, interesting case reports of idiopathic CD4 lymphocytopenia,
renal failure - a reversible cause of complete heart block, an interesting case of hyponatremia and
a covariance case of pulmonary thromboembolism with quadriplegia. These case reports will
elucidate the possible pathogenesis and management of diseases.
Besides these, we have our usual articles on Toxicology, ECG and Dermatology sections.
Hence, I can assure you that this edition of TAPIJ with its articles on various aspects of
medicine will boost your clinical and academic knowledge.
i
Contents
Review Articles
Case Reports
Toxicology
Dermatology
ECG – Section
Miscellaneous
10. Errata 36
11. Instructions of Authors 37
12. Application Forms 40
ii
TAPI Journal Vol. 6, Issue 2, April - July 2014
Review Article
1
TAPI Journal Vol. 6, Issue 2, April - July 2014
ER, that leads to ER stress and thus causing induces the deranged metabolic equilibrium.
insulin resistance. Obesity is associated with a state of aberrant
2. Increased mitochondrial production of immune activity and increasing risk for associated
reactive oxygen species (ROS) triggers inflammatory diseases, including atherosclerosis,
inflammatory signals which cause protein and diabetes, airway inflammation and fatty liver
lipid oxidation and hyperglycemia1. disease. It has been demonstrated that obesity
overloads the functional capacity of the ER and
3. Stress blocks the body from releasing insulin
that this ER stress leads to insulin resistance by
in type 2 diabetes patients.
the activation of inflammatory signaling
4. It produces ketoacidosis or hypoglycaemia in pathways4, 5. Increased glucose metabolism can
type 1 diabetes. lead to a rise in the mitochondrial production of
5. There is a decrease in antioxidant levels due to ROS in obesity, which activates inflammatory
increased lipid and protein oxidation. pathways6. JNK has recently emerged as a central
6. Decrease in levels of albumin, transferrin, metabolic regulator, playing an important role in
ceruloplasmin and haptoglobins. the development of insulin resistance in obesity7.
7. Stress increases cortisol level, which leads to In obesity, JNK activity, is found to be elevated in
hyperglycemia and obesity by causing a boost the liver, muscle, and fat tissues. Loss of JNK1
in appetite. prevents the development of insulin resistance and
diabetes in both genetic and dietary mouse models
8. Hyperglycemia causes a decrease in NADPH
of obesity.
which regulates the growth and death of the
beta cells. NADPH is an essential antioxidant Adipocytes secrete adipokines, which is
in which all the cellular antioxidants ultimately the pathogenesis of several components of
depend on. metabolic syndrome. Deranged HP axis increase
9. Studies using experimental models suggested the circulating cortisol and visceral fat. This
that the overproduction of TNF-alpha in promotes the release of increased free fatty acids
adipose tissue is an important feature of and thus causes insulin resistance.
obesity and contributes significantly to insulin During obesity, there is an elevation in
resistance2, 3. the levels of certain adipokines such as TNF-
The body handles stress in three ways: alpha, IL-6, leptin and Visfatin (a B cell growth
a) Fight or flight stage - acute stress response. factor). TNF-alpha and IL-6 levels are known to
promote insulin resistance. Leptin has multiple
b) Resistance stage - the stressful stage has
effects on immune function and also suppresses
disappeared, but still the body releases higher
appetite and promotes fatty acid oxidation.
levels of stress hormones.
c) Exhaustion stage - chronic stress. The Adiponectin promotes insulin sensitivity
immune system is affected, causing infection. and has antiinflammatory action. Resistin induces
Long term effects of fighting stress deplete endotoxemia/ inflammation and has variable
the body’s energy stores, causes fatigue, action in obesity. It regulates fasting blood glucose
depression, insomnia, poor appetite, level.
hypertension, diabetes, and dyslipidemia, Chemokines like IL-1, IL-IR, IL-8, IL -10,
contributing to coronary artery disease. IL-18, Monocyte Chemotactic Protein-1 levels,
soluble TNF Receptor, C-reactive protein and
Obesity
haptoglobin were also increased in obesity. IL-8,
The chronic stressful state promotes
MCP-1 and IL-18 are proatherogenic whereas
hypothalamic-pituitary (HP) axis dysfunction. It is
a systemic low grade inflammatory state that
2
TAPI Journal
J Vol. 6,
6 Issue 2, A
April - July 20
014
soluble TNF
T Receptoor, C-reactive protein andd Overrexpression of o C/EBP beeta protein in i the
haptoglob
bin are proinflaammatory cytokines. beta cells of transgenic mice leaads to diabetees and
prevention of accuumulation of this
t protein in n mice
norm malized beta cell mass an nd insulin levels10.
Macrrophages in adipose tisssue are likeely to
contribute to the production n of inflamm matory
mediiators either alone or in concert with
adipo ocytes, which suggests a po
otentially impo ortant
influuence of maccrophages in promoting in nsulin
resisttance11, 12 .
In beta cells, TNF-aalpha and eleevated
levells of free faatty acids stiimulates inhibitory
phossphorylation of serine residues
r of IRS-1
Fig..1. Potential mechhanism of beta celll failure18 (insuulin receptor substrate-1). This phosph horyla-
Inncreased environmenttal stresss tion reduces both the ability off IRS-1 to associate
destabilizees HP axis in geneticallly susceptiblee with the insuulin recepto or and tyrrosine
individuals and causees obesity. In I obesity, a phossphorylation of o IRS-1 in response
r to in
nsulin
decrease in n sex steroidss and growth hormone, thee thereeby inhibitin ng downstreaam signalingg and
malfunctio on of HP axxis and increaased levels off insullin action13.
cortisol arre reported. This rettardation of insulin recceptor
Prolonged exposure to inflaammation duee down nstream signaaling leads to o insulin resistance.
to obesityy leads to inccreased plasmma lipid levelss Receent studies have
h shown thet crucial ro ole of
and the in ncidence of insulin
i resistaance which in
n metaabolic stress in
n the activatio
on of inflamm matory
due course results in fatty liiver disease, signaaling pathwayss.
atheroscleerosis, and diab
betes. The ER stress path hway is a central
c
H
Hence, obesityy promotes states of both h proccess which actiivates both JN NK and IKK. JNK,
chronic low-grade in nflammation and insulin n a miitogen activated protein kiinase gets actiivated
resistance.. It has beeen reported that, in thee by means of various strress stimuli and
absence ofo obesity, infusion
i of animals with h inflammmatory sign nals. Whereass IKK, an en nzyme
inflammattory cytokiness or lipids can
n cause insulin
n comp plex, is invollved in propaagating the cellular
resistance8. respoonse to inflammmation. Inhiibition of ER stress
pathw way via chaaperones or other mechaanisms
Stress and
d Beta cell couldd potentially disable inflaammatory response
D
Diabetes is a multifactoriaal disease. Inn and rescue
r insulin
n action10. Extrracellular meddiators
both types of diabetes, there is a losss of beta celll like cytokines andd lipids or in ntracellular sttresses
function caused by reeducing secreetory capacityy like ER stress orr excess ROSS (reactive oxygen o
and enhan nced apoptossis. Oxidative stress causess speciies) productiion by mito ochondria acttivates
impairmen nt of beta cell function n by reactivee inflammmatory path hways like JNK and IKK. These T
oxygen and
a nitrogen species. Beeta cells aree pathw ways lead to the
t production of inflamm matory
extremely sensitive tow
wards oxidativve stress. Thee mediiators through h transcriptioonal regulation n and
most imp portant target in beta cellss to oxidativee direcct inhibition of insulin signaaling.
insult are KATP chann nels and cell metabolism9.
Other pathways
p likee those meddiated
Loss of functional KATP channells causes an n
throuugh the SO OCS (suppreessor of cyttokine
upregulation of antioxidant enzymes.
signaaling) protein
ns and iNO OS (nitric oxide
3
TAPI Journal Vol. 6, Issue 2, April - July 2014
synthase) are also involved in inflammation- mitochondria, which inflicts oxidative damage,
mediated inhibition of insulin action. increased production of proinflammatory
Transcription factors from the PPAR (peroxisome cytokines and thus activates inflammatory
proliferator activated receptor) and LXR (liver X signaling cascades inside endothelial cells14.
receptor) families, promote nutrient transport and Endothelial injury in the adipose tissue might
metabolism and antagonize inflammatory activity. attract inflammatory cells such as macrophages to
LXR families are nuclear receptors, which regulate this site and further exacerbate the local
lipid metabolism in liver. inflammation.
Conclusion
Stress responses mediate insulin
resistance by inhibiting insulin receptor signaling
pathways. Other pathways, molecules, and
alternative mechanisms and the role of alterations
in mitochondrial function have yet to be
uncovered.
Several studies have been reported on the
association between diabetes and polymorphisms
in the promoters of TNF-alpha and IL-615, 16,
although the well-accepted polymorphism with
type 2 diabetes is found in the gene encoding
PPAR17. Altered activity of PPAR affects
susceptibility to inflammation in obesity. Genetic
variations in the FABP, JNK, IKK, or ER stress
pathways or any other loci are known to modulate
the extent of inflammation and thus insulin
resistance. It defines the risk of individuals for
developing metabolic complication of obesity.
Fig. 2. Possible mechanisms that contribute to β‑cell failure in Besides, diabetes and cardiovascular disease,
diabetes19. inflammation have become an emerging criteria
FABPs (fatty acid binding proteins) seize for linking obesity to airway inflammation and
ligands of these transcription factors and promote asthma, cancer, fatty liver and other pathologies.
to a more inflammatory environment. The cell Henceforth, a better understanding of the
must strike a balance between metabolism and mechanisms that lead from obesity to
inflammation. When there is a state of over inflammation will help to design novel therapies
nutrition, the processes required for response to to reduce the morbidity and mortality of obesity.
nutrients and nutrient utilization, like References
mitochondrial oxidative metabolism and 1. Wellen KE, Hotamisligil GS. Inflammation, stress, and
increasing protein synthesis in the ER, can induce diabetes. J Clin Invest. 2005; 115:1111-9.
the inflammatory response of JNK and thus 2. Hotamisligil GS, Arner P, Caro JF, Atkinson RL,
contributes to insulin resistance1. A second Spiegelman BM. Increased adipose tissue expression of
mechanism that initiates inflammation in obesity is tumor necrosis factor-alpha in human obesity and
insulin resistance. J Clin Invest. 1995; 95:2409-15.
oxidative stress. In hyperglycemia condition,
3. Kern PA, Saghizadeh M, Ong JM, et al. The expression
increased glucose uptake by endothelial cells and
of tumor necrosis factor in human adipose tissue.
adipose tissue causes excess production of ROS in
4
TAPI Journal Vol. 6, Issue 2, April - July 2014
Regulation by obesity, weight loss, and relationship to 13. Aguirre V, Werner ED, Giraud J, et al. Phosphorylation
lipoprotein lipase. J Clin Invest. 1995; 95:2111-9. of Ser307 in insulin receptor substrate-1 blocks
4. Ozcan U, Cao Q, Yilmaz E, Lee AH, et al. Endoplasmic interactions with the insulin receptor and inhibits insulin
reticulum stress links obesity, insulin action, and type 2 action. J Biol Chem. 2002; 277(2):1531-7.
diabetes. Science. 2004; 306:457-61. 14. Brownlee M. Biochemistry and molecular cell biology of
5. Nakatani Y, Kaneto H, Kawamori D, et al. Involvement diabetic complications. Nature. 2001; 414:813–820.
of endoplasmic reticulum stress in insulin resistance and 15. Vozarova B, Fernández-Real JM, Knowler WC, et al.
diabetes. J Biol Chem. 2005; 280:847-51. The interleukin-6 (-174) G/C promoter polymorphism
6. Lin Y, Berg AH, Iyengar P, Lam TK, et al. The is associated with type-2 diabetes mellitus in Native
hyperglycemia-induced inflammatory response in Americans and Caucasians. Hum Genet. 2003; 112:409-
adipocytes: the role of reactive oxygen species. J Biol 13.
Chem. 2005; 280:4617-26. 16. Dalziel B, Gosby AK, Richman RM, et al. Association
7. Hirosumi J, Tuncman G, Chang L, et al. A central role of the TNF-alpha -308 G/A promoter polymorphism
for JNK in obesity and insulin resistance. Nature. 2002; with insulin resistance in obesity. Obes Res. 2002; 10:401-
420(6913):333-6. 7.
8. Yu C, Chen Y, Cline GW, et al. Mechanism by which 17. Florez JC, Hirschhorn J, Altshuler D. The inherited
fatty acids inhibit insulin activation of insulin receptor basis of diabetes mellitus: implications for the genetic
substrate-1 (IRS-1)-associated phosphatidylinositol 3- analysis of complex traits. Annu Rev Genomics Hum Genet.
kinase activity in muscle. J Biol Chem. 2002; 277:50230-6. 2003; 4:257-91.
9. Drews G, Krippeit-Drews P, Düfer M. Oxidative stress 18. Popa S, Mota M. 2013. Beta-Cell Function and Failure
and beta-cell dysfunction. Pflugers Arch. 2010; 460:703- in Type 2 Diabetes, Type 2 Diabetes, Prof. Kazuko
18. Masuo (Ed.), ISBN: 978-953-51-1171-9, InTech, DOI:
10.5772/56467.
10. Matsuda T, Kido Y, Asahara S, Kaisho T, et al. Ablation
of C/EBPbeta alleviates ER stress and pancreatic beta 19. Kitamura, T. The role of FOXO1 in β-cell failure and
cell failure through the GRP78 chaperone in mice. J Clin type 2 diabetes mellitus. Nat Rev Endocrinol. 2013;
Invest. 2010; 120:115-26. 9:615–623.
11. Weisberg SP, McCann D, Desai M, et al. Obesity is
associated with macrophage accumulation in adipose
tissue. J Clin Invest. 2003; 112:1796-808.
12. Xu H, Barnes GT, Yang Q, Tan G, Yang D, et al.
Chronic inflammation in fat plays a crucial role in the
development of obesity-related insulin resistance. J Clin
Invest. 2003; 112:1821-30.
5
TAPI Journal Vol. 6, Issue 2, April - July 2014
Review Article
6
TAPI Journal Vol. 6, Issue 2, April - July 2014
7
TAPI Journal Vol. 6, Issue 2, April - July 2014
8
TAPI Journal Vol. 6, Issue 2, April - July 2014
term. When the patient has more than one For absence seizures, the drugs of choice
unprovoked seizure, the treatment options for are ethosuximide and sodium valproate. In case
initiating the antiepileptic drugs/therapy (AED) is of atypical absence and atonic seizures, the drugs
as follows: of choice are valproate, clonazepam and
Preventative measure has to be taken to lamotrigine. Alternatives are topiramate,
avoid the epileptogenic AEDs for specific seizure clonazepam, zonisamide, felbamate.
types.
Myoclonic seizures can be a part of
In partial seizures, drugs such as generalized seizures and sodium valproate,
gabapentin, lamotrigene, leviteracetam, and clonazepam and clobazam are the drugs of choice.
vigabatrin are avoided. In generalized seizures, Myoclonic jerks when associated with partial
drugs like gabapentin and tiagabine can produce seizures, they are treated as partial seizures.
non-convulsive status. Benzodiazepines are
avoided in tonic seizures. During myoclonic In progressive myoclonic epilepsy
seizures, gabapentin, lamotrigene, tiagabine, syndrome, high dose of piracetam is used in
vigabatrin, diphenylhydantoin and carbamazepine addition to valproate, clonazepam and clobazam.
are avoided.
If myoclonic seizures are associated with
Patients are counseled regarding the ceroid lipofuschinosis, antioxidants are used, while
probability, that about 20% of the seizures may in Unveritch Lundborg syndrome, N-Acetyl
not be easily controlled. They are advised to cysteine is used. In myoclonic seizures associated
adhere to restrictions with reference to avoid the
with mitochondrial cytopathy, sodium valproate
specific precipitating factors. Sleep deprivation,
and phenobarbitone is avoided as they can be
starvation, excessive consumption of cerebral
stimulants like cocoa containing food, alcohol and fatal. Mitochondrial cocktail consisting of co-
fixed flickers, watching television as well as the enzyme Q10, levo carnitine, vitamin B1, vitamin
precipitants cause reflex epilepsies. Treatment E, vitamin C, alpha lipoic acid, vitamin B6,
once initiated, compliance to treatment has to be vitamin K and benzodiazepines are used6.
maintained by both patient and caregiver along Infantile spasms may be symptomatic or
with necessary education regarding the expected
idiopathic and the drug of choice is adreno
efficacy, safety and side effects of the drugs5.
corticotrophic hormone ideally when the slam
Treatment of choice differs based on seizure attacks are associated with hypsarrhythmic EEG.
type It is given as intramuscular injections at 1-3
Partial Seizures mg/kg or 40 IU per day, which can be raised up
This includes simple, complex and to 120 IU. Remission is induced in at least 70% of
secondarily generalized seizures. Drugs of choice the patients in about 3 weeks. Then it is continued
are carbamazepine, oxcarabamazepine, clobazam, for 3 months and tapered. Relapse occurs in about
clonazepam and primidone. The alternatives drugs 30% of the patients after discontinuation. Then it
used are lamotrigine and phenobarbitone. is followed up with sodium valproate and/or
benzodiazepines. Oral steroids can be given
Gabapentin, topiramate, tiagabine, instead of ACTH at 1-2 mg/kg body weight and
levetiracetam and zonisamide can be used as add- continued for 3-5 months. Though there is a good
on therapy. effect on the progression of encephalopathy in
Primary Generalised Tonic Clonic these patients by an unknown mechanism, the side
Seizures effect profile is often severe.
Drugs of choice are valproate, phenytoin, Benefits of extended release AEDs
leviteracetam, and phenobarbitone. Alternatives include fewer fluctuations in blood levels and
are lamotrigine, topiramate and primidone.
9
TAPI Journal Vol. 6, Issue 2, April - July 2014
hence improved seizure control tolerability, less sunlight, reading, hearing music, startle and eating.
frequent dosing and Improved compliance. Avoidance of precipitating factors and
prophylactic anticonvulsants serve to prevent the
Interactions between anti-seizure drugs
attacks. Photochromic glasses can be used for
Carbamazepine when combined with
photosensitive epilepsies. In pharmacotherapy,
phenytoin/phenobarbitone reduces the efficacy by
clonazepam, clobazam, valproate, leviteracetam
increasing its metabolism. Phenytoin when
and zonisamide were used to treat reflex epilepsy.
combined with primidone increases its toxicity by
conversion to phenobarbital. Valproic acid when Epilepsy and Pregnancy
combined with clonazepam may precipitate non Pregnancy poses special risk to both
convulsive status epilepticus. Phenobarbital mother and child. Status epilepticus may
decreases the metabolism and increases toxicity complicate 1–2% of epileptics during labor.
of phenytoin. Seizures can cause fetal loss in addition to hypoxia
induced changes in intrauterine growth. Overall
Interaction with other drugs and fetal anomalies are more in epileptic parents. The
enhanced toxicity: teratogenic antiepileptics are better avoided and
polytherapy is reduced to monotherapy whenever
1 Antibiotics Phenytoin, phenobarbitone,
possible and sustained release preparations are
carbamazepine.
safer than multidosing. It is better to monitor free
2 Anticoagulants Phenytoin and drug levels regularly during pregnancy. Risks of
phenobarbitone. AEDs during pregnancy include fetal congenital
3 Cimetidine Displaces phenytoin, valproat malformations and developmental delay.
and benzodia zepines Teratogenicity has been established for valproate
4 Isoniazid Increases toxicity of which is associated with maximum teratotoxicity
phenytoin in the form of open neural canals. Phenytoin
5 Oral Antiepileptics toxicity produces fetal hydantoin syndrome characterized
contraceptives increased and efficacy by cleft lip, cleft palate, microcephaly and
(OCPs) of OCPs reduced hirsuitism. Minor congenital malformations occur
6 Salicylates Displaces phenytoin and in 6-20% and major abnormalities occur in 4-6%
valproate of infants exposed to these drugs in utero,
compared to 3% in babies of epileptic mothers
7 Theophylline Carbamazepine and
not exposed to drugs.
phenytoin.
Administration of 5 mg folate daily, early
Compliance in Epilepsy in pregnancy may reduce this risk. Perinatal death
Successful treatment requires patient rates of the baby may rise from 1–3.9% in
compliance and noncompliance in the primary controls to 1.3–7.8% in the case of epileptic
cause of breakthrough seizures. mothers. Low birth weight (7-10%) and
Identify and address the reasons for prematurity (4-11%) is associated with higher
noncompliance. Compliance declines as the incidence of epilepsy. Mental retardation is 8% if
number of daily doses increases and maximum only mother is affected, 4% if only the father is
compliance is achieved at once daily dosing7. affected and 25% if both are affected8.
10
TAPI Journal Vol. 6, Issue 2, April - July 2014
serum alpha-fetoprotein (AFP) in the mother for include mitochondrial cocktail (see previous
neural tube defects is recommended in addition to paragraph)6.
first trimester anomaly scanning. Oral
Treating Epilepsy in Renal failure
supplementation of vitamin K 20 mg/day
throughout pregnancy reduces the risk of There is an alteration in the
hemorrhagic disease of the newborn. As an pharmacokinetics profile of AEDS in renal
alternative, 3 doses of 10 mg vitamin K in the last disease. Gastroparesis postpones absorption.
trimester to the mother and 1-2 mg IM to the Decrease in gut cytochrome P-450 metabolism
baby at birth can be given. Elective lower segment and in P-glycoprotein active transport results in
caesarean delivery is done in those with risk of more drug entering the portal circulation.
status epilepticus. 4 mg lorazepam intravenously Albuminuria and acidosis reduce plasma albumin
over 4 minutes is used to treat seizures and and binding affinity leading to increased free drug
pethidine is avoided. Concurrent administration of fraction. Reduced glomerular filtration and tubular
oral contraceptives along with AEDS may lower secretion increased half life of the drugs. Kidneys
serum levels of anti-epileptic drug and precipitate readily excrete water-soluble, low-protein-bound
seizures, therefore, AEDs reduces the efficacy of molecules with a small distribution volume, such
contraceptives. as gabapentin, vigabatrin, levetiracetam, and
topiramate so they can be used safely. In status
Catamenial epilepsy is treated with epilepticus, benzodiazepines combined with
acetazolamide 500mg daily or clobazam 10 mg phenytoin and fosphenytoin can be rapidly
twice daily for 5 days, before the onset of administered IV. Therapeutic range of phenytoin
menstruation. being 5-10 μg/ml and free phenytoin 1-2 μg/mL.
During hemodialysis gabapentin, vigabatrin,
topiramate, phenobarbital, and levetiracetam will
require a supplemental dose. Highly protein
bound AEDs like carbamazepine and valproate,
are less likely to require supplemental doses.
Antibiotics get trapped in the intracranial
compartment and dose adjustments are needed
for those with epileptic potential. In patients with
Fig. 2. Effective and toxic level of some common AEDs kidney stones, drugs like topiramate and
zonisamide are avoided.
Other special situations
Endocrine Disorders
Epilepsy and Porphyria
Carbamazepine, phenytoin, and
AEDs induce hepatic metabolism, phenobarbital (enzyme-inducing properties) may
increasing heme synthesis and therefore have considerable long-term influence on
precipitate porphyric crisis. Gabapentin and hormonal status.
levetiracetam are safe in patients with porphyria
having seizures. When there is a crisis, it is treated They may be implicated in certain bone,
with glucose and hematin infusion. Diazepam may lipid, thyroid, and sex hormone abnormalities.
control seizures9. Some of the new AEDs are less likely to have
such effects. Significant changes on the thyroid
Seizures in Mitochondrial Cytopathy hormone system, i.e., the total and free thyroxine
Anticonvulsants, which are potential levels were significantly lower in children treated
mitochondrial poisons, can be fatal. Therefore, with phenytoin, primidone, and carbamazepine.
avoid phenobarbitone and sodium valproate and Among children and adolescents receiving
11
TAPI Journal Vol. 6, Issue 2, April - July 2014
12
TAPI Journal Vol. 6, Issue 2, April - July 2014
13
TAPI Journal Vol. 6, Issue 2, April - July 2014
14
TAPI Journal Vol. 6, Issue 2, April - July 2014
Case Report
15
TAPI Journal Vol. 6, Issue 2, April - July 2014
16
TAPI Journal Vol. 6, Issue 2, April - July 2014
17
TAPI Journal Vol. 6, Issue 2, April - July 2014
seen in about 10 percent of patients with CNS chronic headache, particularly if the patients also
cryptococcal infections18. Choroid plexus have one of the following characteristics: fever,
involvement in the form of unilateral or bilateral weakness or anorexia, neurological complaints, or
enlargement of the choroid plexus that enhances abnormal neuroradiologic findings. Imaging
on contrast, with trapping of the temporal horns, findings of a strongly enhancing choroid plexus,
is a rare manifestation in immunocompetent cystic lesions in the basal ganglia, meningeal
hosts. Gelatinous pseudocysts and enhancement and an intraventricular lesion in
cryptococcomas in the choroid plexus are such a patient should suggest a diagnosis of
relatively specific for CNS cryptococcosis. cryptococcal infection.
Choroid inflammation can progress to
References
ependymitis, intraventricular synechiae, loculation
1. Centers for Disease Control (CDC). Unexplained CD4+
or enlargement, and entrapment of the temporal T-lymphocyte depletion in persons without evident HIV
horn owing to the obstruction of flow by infection--United States. MMWR Morb Mortal Wkly Rep.
cryptococci21. 1992; 41:541.
2. Smith DK, Neal JJ, Holmberg SD. Unexplained
Treatment of cryptococcal meningitis in
opportunistic infections and CD4+ T-lymphocytopenia
non HIV, non organ transplant patients include an without HIV infection. An investigation of cases in the
induction therapy with amphotericin B (0.7-1.0 United States. The Centers for Disease Control
mg/kg per day) plus flucytosine (100 mg/kg per Idiopathic CD4+ T-lymphocytopenia Task Force. N
day) for 4 weeks or amphotericin B (0.7-1.0 Engl J Med. 1993; 328:373.
mg/kg per day) alone for 4 to 6 weeks, followed 3. Ho DD, Cao Y, Zhu T, et al. Idiopathic CD4+ T-
by consolidation therapy with fluconazole (400- lymphocytopenia - immunodeficiency without evidence
800 mg per day) for 8 weeks and maintenance of HIV infection. N Engl J Med. 1993; 328:380.
therapy with Fluconazole (200 mg per day) for 4. Spira TJ, Jones BM, Nicholson JK, et al. Idiopathic
CD4+ T-lymphocytopenia--an analysis of five patients
6-12 months22, 23. The role of steroids in the
with unexplained opportunistic infections. N Engl J Med.
treatment of cryptococcal meningitis in non-HIV 1993; 328:386.
individuals remain controversial24, 25.
5. Luo L, Li T. Idiopathic CD4 lymphocytopenia and
Five cases of cryptococcal meningitis in opportunistic infection-an update. FEMS Immunol Med
immunocompetent patients have been reported, Microbiol. 2008; 54:283-9.
however estimation of CD4 count was not done 6. Ahmad DS, Esmadi M, Steinmann WC. Idiopathic CD4
Lymphocytopenia: Spectrum of opportunistic infections,
as a part of their study26. Four cases of Idiopathic
malignancies, and autoimmune diseases. Avicenna J Med.
CD4 lymphocytopenia have been reported in 2013;3:37-47
India, all of which presented with cryptococcal
7. Kirtava Z, Blomberg J, Bredberg A, et al. CD4+
infection27-30. Three had cryptococcal meningitis T‑lymphocytopenia without HIV infection: increased
and one had disseminated cryptococcal infection prevalence among patients with primary Sjogren’s
with cavernoesophageal fistula30. Among them syndrome. Clin Exp Rheumatol. 1995; 13:609‑16
three of them survived and one expired29. 8. DeHovitz JA, Feldman J, Landesman S. Idiopathic
CD4+ T‑lymphocytopenia. N Engl J Med. 1993;
Conclusion 329:1045‑6.
CNS cryptococcosis is uncommon in 9. Fantin B, Joly V, Elbim C, et al. Lymphocyte subset
non-immunosuppressed hosts, but it causes counts during the course of community‑acquired
significant mortality and long-term morbidity. It is pneumonia: evolution according to age, human
often not considered during the evaluation of immunodeficiency virus status, and etiologic
microorganisms. Clin Infect Dis. 1996; 22:1096‑8.
non-immunosuppressed patients. Cryptococcal
meningitis should be included in the differential 10. Wilhelm M, Weissinger F, Kunzmann V, Muller JG,
Fahey JL. Idiopathic CD4+ T cell lymphocytopenia
diagnosis for all the patients who present with
evolving to monoclonal immunoglobulins and
18
TAPI Journal Vol. 6, Issue 2, April - July 2014
progressive renal damage responsive to IL‑2 therapy. 20. Graybill JR, Sobel J, Saag M, et al. Diagnosis and
Clin Immunol. 2001; 99:298‑304. management of increased intracranial pressure in
11. Yilmaz‑Demirdag Y, Wilson B, Lowery‑Nordberg M, patients with AIDS and cryptococcal meningitis. The
et al. Interleukin‑2 treatment for persistent cryptococcal NIAID Mycoses Study Group and AIDS Cooperative
meningitis in a child with idiopathic CD4(+) T Treatment Groups. Clin Infect Dis. 2000; 30:47.
lymphocytopenia. Allergy Asthma Proc. 2008; 29:421‑4. 21. Kumari R, Raval M, Dhun A. Cryptococcal choroid
12. Warnatz K, Draeger R, Schlesier M, Peter HH. plexitis: rare imaging findings of central nervous system
Successful IL‑2 therapy for relapsing herpes zoster cryptococcal infection in an immunocompetent
infection in a patient with idiopathic CD4+ T individual. Br J Radiol. 2010; 83:e14-7.
lymphocytopenia. Immunobiology 2000; 202:204‑11. 22. Perfect JR, Dismukes WE, Dromer F, et al. Clinical
13. Cunningham‑Rundles C, Murray HW, Smith JP. practice guidelines for the management of cryptococcal
Treatment of idiopathic CD4 T lymphocytopenia with disease: 2010 update by the infectious diseases society of
IL‑2. Clin Exp Immunol. 1999; 116:322‑5. America. Clin Infect Dis. 2010; 50:291.
14. Trojan T, Collins R, Khan DA. Safety and efficacy of 23. Brouwer AE, Rajanuwong A, Chierakul W, et al.
treatment using interleukin‑2 in a patient with idiopathic Combination antifungal therapies for HIV-associated
CD4(+) lymphopenia and Mycobacterium cryptococcal meningitis: a randomised trial. Lancet 2004;
avium‑intracellulare. Clin Exp Immunol. 2009; 156:440‑5. 363:1764.
15. Netea MG, Brouwer AE, Hoogendoorn EH, et [Link] 24. Saag MS, Graybill RJ, Larsen RA, et al. Practice
patients with cryptococcal meningitis and idiopathic guidelines for the management of cryptococcal disease.
CD4 lymphopenia: defective cytokine production and Infectious Diseases Society of America. Clin Infect Dis.
reversal by recombinant interferon- gamma therapy. Clin 2000; 30:710–8.
Infect Dis. 2004; 39:e83-7. 25. Lane M, McBride J, Archer J. Steroid responsive late
16. Petersen EJ, Rozenberg-Arska M, Dekker AW, et al. deterioration in Cryptococcus neoformans variety gattii
Allogeneic bone marrow transplantation can restore meningitis. Neurology 2004; 63:713–4.
CD4+ T-lymphocyte count and immune function in 26. Sanchetee P. Cryptococcal meningitis in
idiopathic CD4+ T-lymphocytopenia. Bone Marrow immunocompetent patients. J Assoc Physicians India. 1998;
Transplant. 1996; 18:813. 46: 617-619.
17. Pappas PG, Perfect JR, Cloud GA, et al. Cryptococcosis 27. Sharma A, Lal V, Modi M, et al. Idiopathic CD4
in human immunodeficiency virus-negative patients in lymphocytopenia presenting as refractory cryptococcal
the era of effective azole therapy. Clin Infect Dis. 2001; meningitis. Ann Indian Acad Neurol. 2010; 13:136-8.
33:690. 28. Jha S, Ghosh P, Agarwal V. Cryptococcal meningitis
18. Cox, GM, Perfect, JR. Cryptococcus neoformans var unmasking idiopathic CD4 lymphocytopenia. Neurol
neoformans and gattii and Trichosporon species. In: India. 2007; 55:312-4.
Topley and Wilson's Microbiology and Microbial 29. Nair JP, Athavale AU, Gawande S, et al. Disseminated
Infections, 9th ed, Ajello, Edward (Ed), Arnold Press, Cryptococcosis with Caverno-Oesophageal Fistula in a
London 1997. Case of Idiopathic CD4+ T-Lymphocytopenia, J Assoc
19. Charlier C, Dromer F, Lévêque C, et al. Cryptococcal Physicians India. 2014; 62:66-69.
neuroradiological lesions correlate with severity during 30. Augustine R, Khalid M, Misri ZK, Hegde S. Idiopathic
cryptococcal meningoencephalitis in HIV-positive CD4+ T-lymphocytopenia - a diagnostic dilemma. J
patients in the HAART era. PLoS One. 2008; 3:e1950. Assoc Physicians India. 2010; 58:45-7.
19
TAPI Journal Vol. 6, Issue 2, April - July 2014
Case Report
Case Study His arterial blood gas analysis report revealed the
A 64 year old gentleman presented with partial pressures of oxygen (pO2) - 86mm Hg and
acute onset of progressive breathlessness for the carbon dioxide (pCO2) - 29mm Hg and the blood
past one week. His clinical examination revealed pH-7.22. His bicarbonate (HCO3) level was found
the pulse rate of 35 beats per minute, blood to be 11meq/L. The results of hematogram and
pressure of 180/80mmHg, facial puffiness and general biochemistry analyses are as follows:
bilateral pedal edema. hemoglobin was 9.8g/dl, total count was
7900/mm3, blood urea 52mg/dl, serum creatinine
He was a known case of diabetes,
3.6mg/dl, sodium 135meq/L, potassium 5.5
hypertension, chronic kidney disease and lumbar
meq/L, calcium 7.8mg/dl , phosphate 5.5mg/dl
spondylosis. His medication includes metoprolol
and magnesium 2.0 mg/dl. His chest X-ray and
50mg twice a day, clinidipine 10mg twice a day
echocardiogram were within normal limits.
and anti diabetic drugs [glimepiride and
metformin]. Significant bradycardia due to complete
heart block was considered responsible for the
On admission, his electrocardiogram patient symptoms. A temporary pacemaker (VVI
(ECG) revealed a complete heart block with an mode) was implanted to achieve a ventricular rate
atrial rate of 70 beats per minute and slow of 80 beats per minute [Fig. 2].
irregular ventricular rate of 30-50 beats per
minute. The QRS complexes were wide and not
of uniform morphology suggestive of unstable
ventricular escape rhythm [Fig. 1].
20
TAPI Journal Vol. 6, Issue 2, April - July 2014
Discussion
In a case of acquired complete heart
block one should always look for the reversible
causes. The common reversible causes are:
1. Drug induced
2. Acute myocardial infarction
3. Myocarditis
4. Electrolyte/ Acid-Base imbalance
5. Metastasis, infiltration, compression or trauma
of the conduction system.
Fig. 3. Day 2- intrinsic rhythm: evidence for resolving CHB- In case of chronic kidney disease, the
intermittent A-V conduction (the second and third QRS pathologic process of myocardial fibrosis and
complexes in the rhythm strip appear to be the result of metastatic calcification may alter the mechanical
conducted P waves). and electrical components of the myocardium and
conduction system which become sensitive to the
adverse effects of acid-base imbalances. The
milieu of metabolic acidosis, hyperkalemia,
hyperphosphatemia and hypocalcaemia in our
patient of chronic kidney disease who was also on
rate limiting drug (metoprolol) predisposed to the
development of complete heart block.
Though our patient showed gradual
improvement in A-V conduction leading to
avoidance of permanent pacemaker, he will be
watched over closely since the chances of
recurrence of complete heart block are high either
because of progression of primary conduction
disease or worsening of renal function eventually
or both.
Fig. 4. Day 3- Intrinsic Rhythm-2:1 A-V Block, Wide QRS Lesson from this case report
(RBBB, Left Axis Deviation) In a case of the acquired complete heart
block, always look for the reversible causes.
21
TAPI Journal Vol. 6, Issue 2, April - July 2014
Case Report
22
TAPI Journal Vol. 6, Issue 2, April - July 2014
23
TAPI Journal Vol. 6, Issue 2, April - July 2014
24
TAPI Journal Vol. 6, Issue 2, April - July 2014
Case Report
25
TAPI Journal Vol. 6, Issue 2, April - July 2014
26
TAPI Journal Vol. 6, Issue 2, April - July 2014
27
TAPI Journal Vol. 6, Issue 2, April - July 2014
28
TAPI Journal Vol. 6, Issue 2, April - July 2014
Toxicology
Corrosives are the substances that cause 3. What are the possible mechanisms of
both functional and histological damage when toxicity in corrosive agents?
ingested or come into contact with body surfaces Most corrosive agents cause direct
by chemical reactions. They are broadly classified chemical injury. Acidic agents cause protein
as alkalis (pH >7) or acids (pH <7). Originally denaturation resulting in coagulative necrosis.
referring to acids, the term corrosives are now Alkaline agents are more dangerous as they cause
used synonymously with caustics, a term originally liquefactive necrosis resulting in deep and
applied to alkalis. progressive mucosal burns. Other corrosive agents
like oxidants may have reducing, oxidizing,
1. What are the commonly available
denaturing or defatting actions.
corrosive agents?
The commonly available corrosive agents are: 4. What are the influencing factors for
Strong acids and alkalis chemical injury?
Concentrated weak acids and alkalis The pH of the compound/agent
Concentration
Oxidizers (with neutral pH)
Volume ingested
Alkylating agents
Presence or absence of food in the
Dehydrating agents stomach
Halogens and organic halides
5. What are all the clinical features
Phenol suggestive of a severe corrosive injury?
2. Mention the sources of some corrosive Corrosive ingestion may result in
agents? immediate symptoms of injury to the
Table 1. Sources of the corrosive agents gastrointestinal tract:
Compounds Source Mouth and throat pain
Alkali
Drooling of saliva
Sodium hydroxide Detergents, drain and oven
cleaners, button batteries Odynophagia
Sodium hypochlorite Bleach Vomiting
Ammonium Toilet bowl and glass Abdominal pain
hydroxide cleaners, anti-rust products
Sodium Detergents Upper airway injury is the most important
tripolyphosphate immediate life-threat.
Acids
Laryngeal injury and edema presents with:
Hydrochloric acid Metal cleaners
Sulfuric acid Drain cleaners, car batteries
Progressive stridor
Hydrofluoric acids Rust remover, petroleum Hoarseness
industry Respiratory distress
Nitric acid Engraving, electroplating
29
TAPI Journal Vol. 6, Issue 2, April - July 2014
6. What are the corrosive agents that cause Do not administer oral fluids
severe systemic toxicity in addition to
Do not administer activated charcoal
direct corrosive injury?
Corrosive agents that can cause severe Do not attempt pH neutralization
systemic toxicity are furnished below: Do not perform gastric lavage
Table 2. Corrosive agents and systemic toxicity 10. When will you insert a nasogastric tube in
Corrosive agent Systemic toxicity corrosive poisoning?
Large-volume acid ingestions may benefit
Glyphosate Metabolic acidosis, Shock,
Multiple organ dysfunction
from a nasogastric tube suction if performed
syndrome (MODS) rapidly after ingestion. The pyloric sphincter
spasm may prolong contact time of the agent to
Hydrofluoric acid Hypocalcemia
the gastric mucosa for up to 90 minutes. It may
Mercuric chloride Renal failure, Shock prevent small intestine exposure and may be of
Oxalic acid Hypocalcemia, Renal failure particular value following ingestion of zinc
Phenol Coma, Seizures, Hepatotoxicity, chloride, mercuric chloride, or hydrogen fluoride,
Renal failure unless signs of perforation are present. In case of
Picric acid Renal failure alkali, mucosal exposure results in a quick and
Potassium Methemoglobinemia, Multi- deep liquefactive necrosis. Blind insertion may
permangante organ failure result in the perforation of damaged tissues and
hence, it is contraindicated.
Silver nitrate Methemoglobinemia
11. When to perform upper gastrointestinal
7. What are the key components of risk (UGI) endoscopy?
assessment? Endoscopy has been called ‘sine qua non’
Agent(s) - (including pH of corrosive for evaluating patients with corrosive poisoning. It
agents) is generally agreed that patients with intentional
Dose(s) - (including concentration and corrosive ingestions should undergo early
volume for corrosive agents) endoscopy, as ingestions with suicidal intent carry
Time(s) of ingestion high risk of clinically important injury. In
Patient factors (co- morbidities) accidental ingestions, particularly in children, the
Clinical progression decision to perform endoscopy should be based
on signs and symptoms. Currently, early
8. What are the three things to consider endoscopy is recommended after an accidental
while examining the patient’s with corrosive ingestions in adult and pediatric patients
corrosive injuries?
with any obvious signs or symptoms of serious
The absence of lip or oral burns does not
injury. Early endoscopy permits early grading of
exclude significant gastro- esophageal
injuries and helps to determine the treatment plan
burns.
and disposition and nutritional support.
Neutral pH of saliva does NOT mean
corrosive ingestion did not occur 12. How early UGI endoscopy should be
done?
Signs and symptoms correlate poorly with
Tissue friability after a corrosive injury
the extent of gastrointestinal injury.
increases significantly in 24 to 48 hours of post-
9. What are the things one should avoid injury and is maximal between days 5 and 14.
during decontamination of a corrosive Most experts agree that endoscopy should be
ingestion? done within first several hours after ingestion;
Do not induce vomiting ideally UGI endoscopy shall be performed within
30
TAPI Journal Vol. 6, Issue 2, April - July 2014
12 hours and not exceeding 24 hours of post followed by a continuous infusion of 8 mg/hour
ingestion to avoid iatrogenic perforation. for 72 hours.
13. How are the endoscopic findings of 17. What are the determinants for disposition?
corrosive injuries graded? Disposition is determined by the risk
The endoscopic findings of corrosive assessment and the patient’s clinical progression.
injuries are graded as follows:
The possibilities are:
Grade 0 — Normal 1. The patient if asymptomatic at 4 hours of
Grade I — Mucosal edema and post-ingestion, a trial of oral fluids may be
hyperemia given. If this is tolerated well, the patient
Grade IIA — Superficial ulcers, bleeding can be discharged. Some experts suggest
and exudates endoscopy following corrosive ingestion,
Grade IIB — Deep focal or even in asymptomatic patients.
circumferential ulcers 2. The patient if symptomatic (e.g. throat
Grade IIIA — Focal necrosis pain, drooling, pain on attempting to
swallow his own saliva, or has vomiting or
Grade IIIB — Extensive necrosis
abdominal pain), the patient is kept on nil
14. Is there any role for antibiotics in the per mouth and admitted for an
treatment of corrosive injury to the observation and an endoscopy within 24
gastrointestinal tract? hours.
No. Antibiotics are not warranted for 3. If the patient has airway compromise,
corrosive poisoning, unless there is an evidence of take measures to secure the airway and
gastrointestinal perforation such as mediastinitis arrange for ICU admission.
or peritonitis and subsequent severe sepsis.
4. If the patient has an evidence of
15. Is there a role for corticosteroids in the gastrointestinal perforation, sepsis or
treatment of the gastrointestinal tract hemodynamic instability, then arrange for
corrosive injury? an urgent surgical assessment.
The use of corticosteroids for the
treatment of gastrointestinal corrosive injuries 18. What are the complications of corrosive
from alkaline agents is controversial. However, injury to the gastrointestinal tract?
there is no evidence that corticosteroids are Esophageal perforation and mediastinitis
effective in preventing esophageal stricture Perforation of the stomach or small
formation. Furthermore, there are concerns that intestine resulting in peritonitis
corticosteroids may actually increase mortality in Septic shock and MODS
Grade III injuries, by increasing the risk of Esophageal strictures occur in 30% of
infection or conceal the symptoms and signs of patients with Grade IIB or III injury on
perforation. endoscopy
16. Is there any role for proton pump inhibitor Esophageal carcinoma may occur over 40
in corrosive injury to the gastrointestinal years after a Grade II or III corrosive
tract? injury
Yes, there is a definite role. Proton pump
inhibitor suppresses gastric acid secretions and 19. What are the common pitfalls observed?
thereby prevents erosion. It should be Failure to identify the substance ingested,
administered in a dose of 80 mg as bolus IV, measure the pH of the material ingested,
31
TAPI Journal Vol. 6, Issue 2, April - July 2014
32
TAPI Journal Vol. 6, Issue 2, April - July 2014
Dermatology
33
TAPI Journal Vol. 6, Issue 2, April - July 2014
34
TAPI Journal Vol. 6, Issue 2, April - July 2014
ECG - Section
Answer:
The ECG demonstrates sinus rhythm, The combination of RBBB and leftward
bradycardia (45 beats per min), PR interval of axis should intensify the suspicion of biventricular
190msec, incomplete right bundle branch block hypertrophy. An ECG is diagnostic of
(RBBB) pattern and QRS duration of 80msec. The biventricular hypertrophy, if R and S are of equal
QRS axis is leftward. magnitude throughout the precordial leads and
QRS axis is leftwards in a normal positioned heart
The combination of bradycardia and wide
(situs solitus, levocardia).
QRS should always raise the suspicion of A-V
block. If the morphology and the axis of QRS are Hence the diagnosis of the ECG is sinus
suggestive of significant conduction defects as in bradycardia and biventricular hypertrophy.
this ECG viz. an incomplete RBBB pattern,
leftward axis and upper limit of PR interval, the
suspicion of A-V block becomes very strong and
needs to have a closer scrutiny at the blocked P
waves which may fall sometimes on the T waves.
35
ERRATA
The editors and the publisher apologize for the following errors
that happened in our earlier issue
(TAPI Journal Vol. 6, January-March 2014).
2. In Page i, under the Section toxicology, the article title had been
published incorrectly. It should read as “Toxicology Clinics-Bench
to Bedside. Toxic Hypoglycemia: Manifestation and Management
Part-1” instead of as shown.
36
37
38
The Journal of the Association of Physicians of India
(Tamil Nadu State Chapter)
Honorary Editor:
Dr. Vijay Viswanathan, MD, PhD, FICP, FRCP (London), FRCP (Glasgow)
Invitation to submit
TAPIJ invites all the members of the Association of Physicians of India of the
Tamil Nadu State Chapter and other academicians involved in scientific and
clinical research to contribute their research in the form of original
articles/review papers/case reports to this journal. TAPIJ is a quarterly journal
and seeks original, insightful and thought-provoking articles and reviews on all
aspects of clinical and academic research.
All the contributors and co-authors are entitled to receive a free copy of the
journal.
To
The Secretary
Association of Physicians of India – Tamil Nadu State Chapter
Chennai.
Dear Sir,
Kindly enroll me as a Member of API – Tamil Nadu State Chapter. My details are as follows
Name (Surname)
I hereby declare the above particulars given by me are correct and agree to abide by the Rules and Regulations
of the Association.
Signature
Date
The Association of Physicians of India, Turf Estate, No.6 & 7, Off: [Link] Road, Opp. Shakti Mills Compound,
Near Mahalaxmi Station (west), Mumbai - 400 011. Tel: 022-66663224 / 24912218, Fax:022-2492 0263,
Email:api_ho@[Link]